Wells Fargo
UBX

Wells Fargo’s Unity Biotechnology UBX Stock Holding History

Wells Fargo’s Portfolio UBX Stock Details UBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-31
Closed -$12 – 7408
2025
Q2 		$12 Hold
31
– – ﹤0.01% 6891
2025
Q1 		$32 Hold
31
– – ﹤0.01% 6548
2024
Q4 		$30 Sell
31
-30
-49% -$37 ﹤0.01% 6610
2024
Q3 		$90 Sell
61
-43,341
-100% -$63.6K ﹤0.01% 6291
2024
Q2 		$58.6K Sell
43,402
-119
-0.3% -$181 ﹤0.01% 5234
2024
Q1 		$71.4K Buy
43,521
+17
+0% +$29 ﹤0.01% 5088
2023
Q4 		$84K Buy
43,504
+5
+0% +$9 ﹤0.01% 5012
2023
Q3 		$104K Buy
43,499
+2
+0% +$5 ﹤0.01% 4752
2023
Q2 		$111K Buy
43,497
+43,346
+28,706% +$114K ﹤0.01% 4975
2023
Q1 		$247 Sell
151
-1
-0.7% -$4 ﹤0.01% 6717
2022
Q4 		$416 Buy
152
+49
+48% +$142 ﹤0.01% 6432
2022
Q3 		$0 Sell
103
-6
-6% -$38 ﹤0.01% 7396
2022
Q2 		$0 Sell
109
-13
-11% -$108 ﹤0.01% 7517
2022
Q1 		$2K Buy
122
+20
+20% +$224 ﹤0.01% 6704
2021
Q4 		$1K Buy
102
+21
+26% +$459 ﹤0.01% 7085
2021
Q3 		$2K Hold
81
– – ﹤0.01% 6597
2021
Q2 		$4K Sell
81
-909
-92% -$43.8K ﹤0.01% 6415
2021
Q1 		$60K Sell
990
-5,552
-85% -$379K ﹤0.01% 5736
2020
Q4 		$343K Buy
6,542
+4,474
+216% +$216K ﹤0.01% 4795
2020
Q3 		$71K Sell
2,068
-11,992
-85% -$759K ﹤0.01% 5386
2020
Q2 		$1.22M Buy
14,060
+11,925
+559% +$884K ﹤0.01% 3651
2020
Q1 		$124K Buy
2,135
+478
+29% +$30.1K ﹤0.01% 4955
2019
Q4 		$119K Buy
1,657
+7
+0.4% +$494 ﹤0.01% 5217
2019
Q3 		$101K Buy
1,650
+110
+7% +$7.78K ﹤0.01% 5314
2019
Q2 		$147K Buy
1,540
+95
+7% +$8.08K ﹤0.01% 5133
2019
Q1 		$118K Sell
1,445
-1,850
-56% -$210K ﹤0.01% 5077
2018
Q4 		$536K Buy
3,295
+3,061
+1,308% +$406K ﹤0.01% 4287
2018
Q3 		$38K Buy
234
+152
+185% +$25K ﹤0.01% 5678
2018
Q2 		$12K Buy
+82
New +$12K ﹤0.01% 5921

Other funds holding UBX

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
AIP
Ameritas Investment Partners Lincoln, Nebraska $3.25B AUM 28.52% 1-Year Est. Return
AWM
AllSquare Wealth Management Albany, New York $189M AUM 14.89% 1-Year Est. Return

Wells Fargo's UBX Position: Q3 2025 in Review

Wells Fargo sold out of Unity Biotechnology (UBX) in Q3 2025, closing a stake of 31 shares — an estimated $12 sold.

Wells Fargo first reported a position in UBX in Q2 2018 and held it in 29 quarters. The position peaked at $1.22M in Q2 2020. 6 funds tracked by Wall St. Rank hold UBX as of Q3 2025.

  • Wells Fargo reported no remaining Unity Biotechnology position as of Q3 2025 after selling out during the quarter.
  • Wells Fargo sold 31 Unity Biotechnology shares in Q3 2025, an estimated $12.
  • Wells Fargo first reported a position in Unity Biotechnology in Q2 2018 and held it in 29 quarters.
  • Wells Fargo's Unity Biotechnology position peaked at $1.22M in Q2 2020.
  • 6 funds tracked by Wall St. Rank held Unity Biotechnology as of Q3 2025.

Based on Wells Fargo's 13F filing for Q3 2025, filed 13 Nov 2025.